About the Glaucoma Session
Glaucoma addresses the diagnosis, monitoring, treatment, and prevention of progressive optic nerve damage associated with this major cause of irreversible vision loss. The session highlights advances in imaging, medical therapy, laser treatment, conventional surgery, minimally invasive procedures, risk assessment, neuroprotection, and long-term disease management.
Abstract Scope and Participation
Submissions may explore glaucoma mechanisms, diagnostics, imaging, medical treatments, surgical approaches, MIGS, disease progression, screening, adherence, outcomes, and novel therapeutic strategies. Glaucoma specialists, ophthalmologists, researchers, vision scientists, clinicians, and professionals developing diagnostic or therapeutic technologies are encouraged to participate.
Topics Covered in Glaucoma
Topic 01
Glaucoma Diagnosis
Topic 02
Medical Therapy
Topic 03
Glaucoma Surgery
Topic 04
MIGS
Topic 05
Glaucoma Imaging
Topic 06
Disease Progression
Featured Speakers — Glaucoma 2027
Browse all speakers →
Recent Research Presented at Glaucoma Sessions
A comparative analysis of visual outcome predictions using a retinal acuity meter in cataract patients with coexisting glaucoma
Objective: To compare preoperative visual acuity predicted using a Retinal Acuity Meter (RAM) with the actual best-corrected visual acuity (BCVA) one month after cataract surgery in patients with…
Transient hypotony maculopathy and choroidal effusion after 5-fluorouracil–augmented bleb needling in an eye with a pre-existing Ahmed valve: A case report
Case Presentation: A 43-year-old man with primary open-angle glaucoma of the right eye had undergone Ahmed valve implantation two years earlier and bilateral trabeculectomy with mitomycin C one year…
Advanced 3D human-based in vitro models to identify glaucoma-specific molecular markers and to study the pathological crosstalk leading to neuroinflammation
Retinal cell death is a common pathological hallmark of several neurodegenerative diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration. Among these, Primary…
Deep learning-based glaucoma classification from fundus images: Comparative analysis of CNN architectures
Glaucoma represents a leading cause of irreversible blindness worldwide, characterized by progressive optic nerve damage that often progresses asymptomatically until significant vision loss occurs.…
Minimally Invasive Glaucoma Surgery (MIGS) with iStent inject W in Primary Open-Angle Glaucoma (POAG): Clinical outcomes and best practices
Object: Primary Open-Angle Glaucoma (POAG) remains a leading cause of irreversible blindness, with Minimally Invasive Glaucoma Surgery (MIGS) emerging as a pivotal strategy for early-stage…
Comparative outcomes of a newly modified trabeculectomy versus conventional trabeculectomy
This prospective comparative study evaluated the outcomes of a Newly Modified Trabeculectomy (NMT) versus conventional Trabeculectomy (trab) in patients with open-angle glaucoma, with a special…
Related Scientific Sessions at IOC 2027
Why Attend the Glaucoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Glaucoma work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Glaucoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Glaucoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Glaucoma Conference 2027 — FAQs
What is the Glaucoma track at IOC 2027?
The Glaucoma track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Glaucoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Glaucoma sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Glaucoma are all welcome — whether presenting or attending.
Can I present my research in the Glaucoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Glaucoma sessions?
Yes. IOC 2027 is a hybrid conference — attend the Glaucoma track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.